XML 43 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
11. Segment Information
 9 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Segment Information
11.    SEGMENT INFORMATION

Information regarding industry segments for the three months ended September 30, 2014 and 2013 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2014
$
172.8

 
$
354.7

 
$
3.1

 
2013
$
162.9

 
$
338.8

 
$
3.4

 
 
 
 
 
 
 
Segment net (loss) profit
2014
$
(10.6
)
 
$
47.8

 
$
0.1

 
2013
$
(8.5
)
 
$
43.0

 
$
—


Information regarding industry segments for the nine months ended September 30, 2014 and 2013 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2014
$
504.6

 
$
1,062.0

 
$
10.2

 
2013
$
489.5

 
$
1,030.2

 
$
10.4

 
 
 
 
 
 
 
Segment net (loss) profit
2014
$
(24.5
)
 
$
130.3

 
$
0.4

 
2013
$
(28.9
)
 
$
130.6

 
$
0.3


Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance.  Net corporate operating, interest and other expense for segment results consists of receipts and expenditures that are not the primary responsibility of segment operating management and therefore are not allocated to the segments for performance assessment by our chief operating decision maker.  The three and nine months ended September 30, 2014 included additional accrual adjustments of $12.1 million and $20.1 million, respectively, in connection with reaching our final settlement with the SEC and DOJ investigations relating to the United States Foreign Corrupt Practices Act (FCPA) (see Note 12). The three and nine months ended September 30, 2013 included the accrual of $20.0 million in connection with our initial efforts to resolve the SEC and DOJ investigations relating to the FCPA and a $15.6 million loss on extinguishment of our 8.0% Senior Subordinated Notes. Interest expense is charged to segments based on the carrying amount of inventory and receivables employed by that segment.  The following reconciles total segment profit to consolidated income (loss) before taxes (in millions):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2014
 
2013
 
2014
 
2013
Total segment profit
$
37.3

 
$
34.5

 
$
106.2

 
$
102.0

Foreign currency exchange losses, net
(3.7
)
 
(3.3
)
 
(6.1
)
 
(5.7
)
Net corporate operating, interest and other expense not allocated to segments
(11.7
)
 
(37.1
)
 
(24.0
)
 
(39.1
)
Other income (expense), net
0.6

 
0.7

 
9.7

 
10.7

Consolidated income (loss) before income taxes
$
22.5

 
$
(5.2
)
 
$
85.8

 
$
67.9